Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: The TROIA trial

JACC: Cardiovascular Imaging

Volumn 6, Issue 2, 2013, Pages 206-216

  Özkan, Mehmet ^a   Gündüz, Sabahattin ^a   Biteker, Murat ^a   Astarcioglu, Mehmet Ali ^a   Çevik, Cihan ^b   Kaynak, Evren ^c   Yildiz, Mustafa ^a   Oǧuz, Emrah ^a   Aykan, Ahmet Çaǧri ^a   Ertürk, Emre ^a   Karavelioǧlu, Yusuf ^a   Gökdeniz, Tayyar ^a   Kaya, Hasan ^a   Gürsoy, Ozan Mustafa ^a   Çakal, Beytullah ^a   Karakoyun, Süleyman ^a   Duran, Nilüfer ^a   Özdemir, Nihal ^a  

^a Kosuyolu Kartal Heart Training and Research Hospital   (Turkey)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Prosthetic valve thrombosis; Thrombolytic therapy; Transesophageal echocardiography

Indexed keywords

STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG MEGADOSE; EMBOLISM; EPISTAXIS; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; GINGIVA BLEEDING; HEMOPTYSIS; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VAGINA BLEEDING; VERY ELDERLY; YOUNG ADULT; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG ADMINISTRATION; ECHOGRAPHY; EQUIPMENT; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; INFUSION; METHODOLOGY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROSTHESIS; PROSTHESIS FAILURE; RISK; RISK FACTOR; STATISTICAL MODEL; THROMBOSIS; TIME; TREATMENT OUTCOME; TURKEY (REPUBLIC); TURKEY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRINOLYTIC AGENTS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; INFUSIONS, PARENTERAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; STREPTOKINASE; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 84880918859     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.10.016     Document Type: Article

References (29)

1. Edmunds LH Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad hoc liaison committee for standardizing definitions of prosthetic heart valve morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112: 708 -11.
2. Grunkemeier GL, Rahimtoola SH. Artificial heart valves. Annu Rev Med 1990;41: 251-63.
3. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89: 635-41.
4. Laplace G, Lafitte S, Labeque JN, et al. Clinical significance early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J Am Coll Cardiol 2004;43: 1283-90.
5. Ozkokeli M, Sensoz Y, Ates M, Ekinci A, Akcar M, Yekeler I. Surgical treatment of prosthetic valve thrombosis-short and long-term results. Int Heart J 2005;46: 105-11.
6. Toker ME, Eren E, Balkanay M, et al. Multivariate analysis for operative mortality in prosthetic valve dysfunction due to pannus and thrombus formation. Int Heart J 2006;47: 237-45.
7. Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 1991;17: 646 -50.
8. Durrleman N, Pellerin M, Bouchard D, et al. Prosthetic valve thrombosis: twenty year-experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg 2004;127: 1388 -92.
9. Lengyel M, Vegh G, Vandor L. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. J Heart Valve Dis 1999;8: 167-73.
10. Özkan M, Kaymaz C, Kirma C, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol 2000;35: 1881-9.
11. Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K, et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. J Thromb Thrombolysis 2006;21: 185-90.
12. Shapira Y, Vaturi M, Sagie A. Obstructive left-sided prosthetic valve thrombosis. Acute Card Care 2009; 11: 160-8.
13. Alpert JS. The thrombosed prosthetic valve: current recommendations based on evidence from the literature. J Am Coll Cardiol 2003;41: 659-60.
14. Karthikeyan G, Math RS, Mathew N, et al. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 2009;120: 1108 -14.
15. Tong AT, Roudaut R, Ozkan M, et al. Prosthetic Valve Thrombolysis-Role of Transesophageal Echocardiography (PRO-TEE) Registry Investigators; transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry. J Am Coll Cardiol 2004;43: 77-84.
16. Roudaut R, Lafitte S, Roudaut MF, et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a single center study of 127 cases. J Am Coll Cardiol 2003;41: 653-8.
17. Gupta D, Kothari SS, Gahl VK, et al. Thrombolytic therapy for prosthetic valve thrombosis: short- and longterm results. Am Heart J 2000;140: 906-16.
18. Koller PT, Arom KV. Thrombolytic therapy of left sided prosthetic valve thrombosis. Chest 1995;108: 1683-9.
19. Biteker M, Duran NE, Gündüz S, et al. Thrombolysis of an acute prosthetic mitral valve thrombosis presented with cardiogenic shock under the guidance of continuous transoesophageal monitoring. Eur J Echocardiogr 2009;10: 468 -70.
20. Nagy A, Denes M, Lengyel M. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events. J Heart Valve Dis 2009;18: 268 -75.
21. Renzulli A, Vitale N, Caruso A, et al. Thrombolysis of prosthetic valve thrombosis: indications and results. J Heart Valve Dis 1997;6: 212-8.
22. Denofrio D, Ament AF, Mark JB, George SF. Accelerated TPA for treatment of prosthetic valve thrombosis. Clin Cardiol 1996;19: 665-8.
23. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-142.
24. Vahanian A, Baumgartner H, Bax J, et al., Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28: 230-68.
25. Lengyel M, Horstkotte D, Voller H, Mistiaen WP. Working group infection, thrombosis, embolism and bleeding of the society for heart valve disease. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005; 14: 567-75.
26. Salem DN, O'Gara PT, Madias C, Pauker SG, American College of Chest Physicians. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Practice Guidelines (8th Edition). Chest 2008;133: 593-629.
27. Keuleers S, Herijgers P, Herregods MC, et al. Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis. Am J Cardiol 2011;107: 275-9.
28. Cevik C, Izgi C, Dechyapirom W, Nugent K. Treatment of prosthetic valve thrombosis: rationale for a prospective randomized clinical trial. J Heart Valve Dis 2010;19: 161-70.
29. Ozkan M, Biteker M, Duran NE, Yildiz M. Images in cardiovascular medicine. Huge prosthetic mitral valve thrombosis in a pregnant woman. Circulation 2009;120:e151-2.